In an effort to make the Aasandha system more sustainable while also maintain quality service provision, National Social Protection Agency (NSPA) announced last night that the prices of 250 widely used medicines in the Maldives will be controlled starting next month.
NSPA expects these measures to reduce the cost of overpriced medicines, saving approximately MVR 220 million annually under the Aasandha scheme.